Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women

Menopause

Volumn 17, Issue 2, 2010, Pages 403-409

  Sherwood, Andrew ^a   Park, Sat Byul ^a,b   Hughes, Joel W ^c   Blumenthal, James A ^a   Hinderliter, Alan ^d   Trivedi, Ranak ^a   McFetridge Durdle, Judith ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Ajou University School of Medicine   (South Korea)

^c KENT STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adrenergic receptors; Cardiovascular; Catecholamines; Hemodynamics; Menopause

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE; CHOLESTEROL; CREATININE; ESTROGEN; FOLLITROPIN; GLUCOSE; LUTEINIZING HORMONE; NORADRENALIN; PROGESTERONE; TRIACYLGLYCEROL;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATECHOLAMINE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSE; MENTAL STRESS; NORADRENALIN BLOOD LEVEL; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; REST; SYSTEMIC VASCULAR RESISTANCE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; FEMALE; HEMODYNAMICS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE;

EID: 77949350535     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181b9b061     Document Type: Article

References (46)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
2. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89:157-161.
3. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-452.
4. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981;139:47-51.
5. World Health Organization. Vital statistics and causes of death. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1982.
6. Utian WH. Biosynthesis and physiologic effects of estrogen and pathophysiologic effects of estrogen deficiency: a review. Am J Obstet Gynecol 1989;161:1828-1831.
7. La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E, Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol 1987;157: 1108-1112.
8. Mercuro G, Longu G, Zoncu S, Cherchi A. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. Am Heart J 1999;137:692-697.
9. Mercuro G, Pitzalis L, Podda A, et al. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. Am J Cardiol 1999;84:214-218.
10. Mercuro G, Podda A, Pitzalis L, et al. Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol 2000;85:787-789.
11. Mercuro G, Zoncu S, Cherchi A, Rosano GM. Can menopause be considered an independent risk factor for cardiovascular disease?. Ital Heart J 2001;2:719-727.
12. Lin AL, McGill HC, Jr, Shain SA. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myo-cardial cytoplasmic progesterone receptors. Circ Res 1982;50:610-616.
13. Lin AL, Gonzalez R Jr, Carey KD, Shain SA. Estradiol-17A affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986;6:495-504.
14. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH. Development and evaluation of an impedance cardiac output system. Aerosp Med 1966;37:1208-1212.
15. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJP. Methodological guidelines for impedance cardiography. Psychophysiology 1990;27:1-23.
16. Ironson G, Taylor CB, Boltwood M, et al. Effects of anger on left ventricular ejection fraction in coronary artery disease. Am J Cardiol 1992;70:281-285.
17. Devereux RB, Savage DD, Sachs I, Laragh JH. Relation of hemody-namic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 1983;51:171-176.
18. Blumenthal JA, Jiang W, Waugh RA, et al. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. Circulation 1995;92:2102-2108.
19. Girdler SS, Hinderliter AL, Light KC. Peripheral adrenergic receptor contributions to cardiovascular reactivity: influence of race and gender. J Psychosom Res 1993;37:177-193.
20. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989;13:647-655.
21. Cleaveland CR, Rangno RE, Shand DG. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propran-olol. Arch Intern Med 1972;130:47-52.
22. Kotchen TA, Guthrie GP, McKean H, Kotchen JM. Adrenergic responsiveness in prehypertensive subjects. Circulation 1982;65:285-290.
23. Light KC, Hinderliter AL, West SG, et al. Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens 2001;19:269-278.
24. Kamali P, Muller T, Lang U, Clapp JF III. Cardiovascular responses of perimenopausal women to hormonal replacement therapy. Am J Obstet Gynecol. 2000;182:17-22.
25. Staessen JA, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997;11:507-514.
26. Owens JF, Stoney CM, Matthews KA. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993;88:2794-2802. See comments.
27. Hinderliter AL, Sherwood A, Blumenthal JA, et al. Changes in hemo-dynamics and left ventricular structure after menopause. Am J Cardiol 2002;89:830-833.
28. Blum I, Vered Y, Lifshitz A, et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996;32:1158-1162.
29. Sudhir K, Elser MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997;30:1538-1543.
30. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-476.
31. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576-582.
32. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929-933.
33. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234.
34. Zeiher AM, Drexter H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-662.
35. Blumenthal RS, Brinker JA, Resar JR, et al. Long-term estrogen therapy abolishes acute estrogen-induced coronary augmentation in postmeno-pausal women. Am Heart J 1997;133:323-328.
36. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90:786-791.
37. Collins P, Rosano GMC, Sarrel PM, et al. 17A-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30.
38. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women [comment]. Hypertension 1996;28:330-334.
39. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO, III. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997;96:2795-2801.
40. Lang U, Baker RS, Clark KE. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis. Eur J Obstet Gynecol Reprod Biol 1997;74:229-235.
41. Zaydun G, Tomiyama H, Hashimoto H, et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. Atherosclerosis 2006;184:137-142.
42. Mercuro G, Zoncu S, Saiu F, Mascia M, Melis GB, Rosano GM. Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis. Maturitas 2004;47:131-138.
43. Ghiadoni L, Donald AE, Cropley M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000;102:2473-2478.
44. Sherwood A, Johnson K, Blumenthal JA, Hinderliter AL. Endothelial function and hemodynamic responses during mental stress. Psychosom Med 1999;61:365-370.
45. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000;101:862-868.
46. McFetridge JA, Sherwood A. Hemodynamic and sympathetic nervous system responses to stress during the menstrual cycle. AACN Clin Issues 2000;11:158-167.